The U.S. DEA (Drug Enforcement Administration) is reclassifying marijuana as a less-dangerous drug, according to Associated Press (AP) reports, which has sharply strengthened shares among traded companies linked to the canopy sector. Media sources suggest also that the U.S. Justice Department will recommend marijuana to be classified as schedule 3 instead of schedule 1, essentially making it a less serious criminal offense. The stock of Canopy Growth (CGC.US) is currently gaining 24%. Aurora Cannabis (ACB.US) shares are gaining more than 17% amid this information, which may be a 'historic shift'.
Source: xStation
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appThe material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.